Ecstasy and neurodegeneration.
作者信息
Green A R, Goodwin G M
出版信息
BMJ. 1996 Jun 15;312(7045):1493-4. doi: 10.1136/bmj.312.7045.1493.
Abstract
摘要
相似文献
1
Ecstasy and neurodegeneration.摇头丸与神经退行性变
BMJ. 1996 Jun 15;312(7045):1493-4. doi: 10.1136/bmj.312.7045.1493.
2
Ecstasy in the brain: a model for neuroimaging.大脑中的摇头丸：一种神经成像模型。
J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):125-9. doi: 10.1176/jnp.14.2.125.
3
[Ecstasy is a dangerous drug the society chooses to ignore].摇头丸是一种社会选择忽视的危险毒品。
Lakartidningen. 2003 Feb 27;100(9):688-90.
4
Caveat emptor: editors beware.买者自慎：编辑需谨慎。
Neuropsychopharmacology. 2001 Mar;24(3):333-6. doi: 10.1016/S0893-133X(00)00171-8.
5
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?亚甲二氧基苯丙胺（摇头丸）对人体的神经毒性：持续性脑损伤的证据有多确凿？
Addiction. 2006 Mar;101(3):348-61. doi: 10.1111/j.1360-0443.2006.01314.x.
6
Is a single dose of MDMA harmless?单剂量的摇头丸无害吗？
Neuropsychopharmacology. 1999 Oct;21(4):598-600. doi: 10.1016/S0893-133X(99)00032-9.
7
[Toxicity of ecstasy].
Med Clin (Barc). 1998 Oct 24;111(13):516-7.
8
Parkinsonism after taking ecstasy.服用摇头丸后出现帕金森综合征。
N Engl J Med. 1999 May 6;340(18):1443. doi: 10.1056/nejm199905063401817.
9
[Ecstasy: a falsely safe drug].摇头丸：一种被误以为安全的毒品
Med Clin (Barc). 1998 Feb 7;110(4):156.
10
What should the public be told about the risks of ecstasy?应该向公众告知摇头丸的哪些风险？
JAMA. 2002 Feb 6;287(5):585.
引用本文的文献
1
Attenuates MDMA-Induced Neuroinflammation in the CA1 Region of the Hippocampus in the Rat Model.减轻大鼠模型中海马体CA1区3,4－亚甲基二氧甲基苯丙胺（MDMA）诱导的神经炎症。
Ann Neurosci. 2020 Jul;27(3-4):104-113. doi: 10.1177/0972753120966852. Epub 2021 Jan 22.
2
Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.翻译：翻译失真：关于 3,4-亚甲二氧基甲基苯丙胺的临床前研究提供了作用机制方面的信息，但不能准确预测人类的不良事件。
Br J Pharmacol. 2012 Jul;166(5):1523-36. doi: 10.1111/j.1476-5381.2011.01819.x.
3
Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats.氯氮平可逆转3,4-亚甲基二氧甲基苯丙胺（摇头丸）在兔和大鼠中引起的体温过高以及交感神经介导的皮肤血管收缩。
J Neurosci. 2003 Jul 16;23(15):6385-91. doi: 10.1523/JNEUROSCI.23-15-06385.2003.
4
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.摇头丸（MDMA，即“迷幻药”）在人体中的非线性药代动力学。
Br J Clin Pharmacol. 2000 Feb;49(2):104-9. doi: 10.1046/j.1365-2125.2000.00121.x.
5
Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.3,4-亚甲基二氧甲基苯丙胺（摇头丸，MDMA）及其同系物的摄入所引发的血清素能突触前膜丧失的原因及后果。
J Neural Transm (Vienna). 1997;104(8-9):771-94. doi: 10.1007/BF01285547.
6
Ecstasy and neurodegeneration. gamma-Hydroxybutyrate is a new recreational drug that may lead to loss of consciousness.摇头丸与神经退行性变。γ-羟基丁酸是一种新型消遣性药物，可能导致意识丧失。
BMJ. 1996 Aug 17;313(7054):424. doi: 10.1136/bmj.313.7054.424a.
7
Ecstasy and neurodegeneration. ...such as ketamine.摇头丸与神经退行性变……比如氯胺酮。
BMJ. 1996 Aug 17;313(7054):424. doi: 10.1136/bmj.313.7054.424.
8
Ecstasy and neurodegeneration. Tablets often contain substances in addition to, or instead of, ecstasy..摇头丸与神经退行性变。片剂中除摇头丸外，或不含摇头丸，还常含有其他物质。
BMJ. 1996 Aug 17;313(7054):423-4. doi: 10.1136/bmj.313.7054.423b.
9
Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.摇头丸与神经退行性变。不存在神经毒性证据。
BMJ. 1996 Aug 17;313(7054):423. doi: 10.1136/bmj.313.7054.423a.
10
Ecstasy and neurodegeneration. Advice is that "less is more".摇头丸与神经退行性变。建议是“越少越好”。
BMJ. 1996 Aug 17;313(7054):423. doi: 10.1136/bmj.313.7054.423.
本文引用的文献
1
The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.自旋捕捉试剂α-苯基-N-叔丁基硝酮可防止“摇头丸”诱导的5-羟色胺神经元神经变性。
Eur J Pharmacol. 1995 Jul 14;280(3):343-6. doi: 10.1016/0014-2999(95)00298-y.
2
Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy').与使用3,4-亚甲基二氧甲基苯丙胺（“摇头丸”）相关的精神病理学多样性。
Br J Psychiatry. 1994 Sep;165(3):391-5. doi: 10.1192/bjp.165.3.391.
3
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.正电子发射断层扫描证据表明人类MPTP诱导的多巴胺能损伤在进展。
Ann Neurol. 1994 Nov;36(5):765-70. doi: 10.1002/ana.410360513.
4
New Targets for Long Acting Drugs Involving Translocation to the Nucleus. Proceedings of the 6th Biochemical Pharmacology Symposium. Oxford, 22-23 July 1993. Dedicated to Professor Peter Alexander PhD, Dsc. 1922-1993.涉及核易位的长效药物新靶点。第六届生化药理学研讨会论文集。牛津，1993年7月22日至23日。献给彼得·亚历山大教授，哲学博士，理学博士。1922 - 1993年。
Biochem Pharmacol. 1994 Jan 13;47(1):1-154.
5
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").3,4－亚甲基二氧甲基苯丙胺（摇头丸或“迷幻药”）的药理学与临床药理学综述
Psychopharmacology (Berl). 1995 Jun;119(3):247-60. doi: 10.1007/BF02246288.
6
Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").在先前接触过消遣性药物（±）3,4-亚甲基二氧甲基苯丙胺（摇头丸，“迷幻药”）的动物中，5-羟色胺轴突上行投射的重组。
J Neurosci. 1995 Aug;15(8):5476-85. doi: 10.1523/JNEUROSCI.15-08-05476.1995.
7
The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.“摇头丸”（3,4－亚甲基二氧甲基苯丙胺，MDMA）和3,4－亚甲基二氧苯丙胺（MDA）对黑褐大鼠（DA大鼠）的热效应和神经毒性作用，DA大鼠是细胞色素P450 2D6代谢不良者表型的模型。
Br J Pharmacol. 1995 Aug;115(7):1281-9. doi: 10.1111/j.1476-5381.1995.tb15037.x.
8
Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.（±）3,4-亚甲基二氧甲基苯丙胺（摇头丸；“摇头丸”）后的血清素神经毒性：一项人体对照研究。
Neuropsychopharmacology. 1994 Apr;10(2):129-38. doi: 10.1038/npp.1994.15.
9
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.人类因哌替啶类似物合成产物导致的慢性帕金森症。
Science. 1983 Feb 25;219(4587):979-80. doi: 10.1126/science.6823561.
Zotero 插件